Abstract
It is imperative that new therapeutic options be evaluated to identify those that may successfully circumvent chemoresistance in ovarian cancer and improve long-term outcomes. This chapter describes preclinical and clinical studies investigating novel therapies and potential preventive agents that may hold promise in future clinical applications in ovarian cancer treatment and control.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
